|
Rekha C. PatelAssociate Professor of Biological SciencesPh. D. 1987, Indian Institute of Science 803-777-1853 patelr@biol.sc.edu
|
Fasciano, S., Kaufman, A., and Patel, R. C. (2007) Expression of PACT is regulated by Sp1 transcription factor. Gene, 388(1-2), 74-82.
Fasciano, S., Patel, R. C., Handy, I., and Patel, C. V. (2005) Regulation of vascular smooth muscle proliferation by heparin: Inhibition of cyclin-dependent kinase 2 activity by p27kip1. J. Biol. Chem. 280(16), 15682-15689.
Fasciano, S., Hutchins, B., Handy, I., and Patel, R. C. (2005) Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR. FEBS Journal 272(6), 1425-1439.
Gupta, V., Huang, X., and Patel, R. C. (2003) The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity. Virology 315, 283-291.
Gupta, V., and Patel, R. C. (2002) Proapoptotic protein PACT is expressed at high levels in colonic epithelial cells in mice. Am. J. Gastrointest. Liver Physiol. 283, G801-G808.
Huang, X., Hutchins, B., and Patel, R. C. (2002) The carboxy-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem. J. 366, 175-186.
Patel, R. C. , Handy, I., Patel, C. V. (2002) Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 221, 439-1444.
Patel, C. V., Handy, I., Goldsmith, T., and Patel, R. C. (2000) PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275, 37993-37998.
Patel, R. C. , Vestal, D. J., Xu, Z., Bandyopadhyay, S., Guo, W., Erme, S. M., Wiliams, B. R. G. and Sen, G. C. (1999) DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J. Biol. Chem. 274, 20432-20437.
Patel, R. C. and Sen, G. C. (1998) Requirement of PKR dimerization mediated by specific hydrophobic residues for its activation by double-strandedRNA and its antigrowth effects in yeast. Mol Cell. Biol. 18, 7009-7019.
Patel, R. C. and Sen, G. C. (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17, 4379-4390.
Patel, R. C. , Stanton, P. and Sen, G. C. (1996) Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271, 25657-25663.
Patel, R. C. , Stanton, P., McMillan, N. M. J., Williams, B.R.G., and Sen, G.C.(1995) The interferon-inducible double-stranded RNA-activated protein kinase, PKR, self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 92, 8283-8287.
Patel, R. C. and Sen, G. C. (1994) Characterization of the interactions between double-stranded RNA and the double-stranded RNA binding domain of the interferon induced protein kinase. Cell. Mol. Biol. Res. 40, 671-682.
Patel, R. C. , Stanton, P. and Sen, G. C. (1994) Role of the amino terminal residues of the interferon induced protein kinase in its activation by double-stranded RNA and Heparin. J. Biol. Chem. 269, 18593-18598.
Patel, R. C. and Sen, G. C. (1992) Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267(11), 7671-7676.